Login
From:
Alzheimer's News Today
(Uncensored)
subscribe
Kisunla (donanemab-azbt) for Alzheimer’s – Alzheimer's News Today
https://alzheimersnewstoday.com/ly3002813/
links
backlinks
Kisunla (donanemab-azbt) is an antibody-based therapy approved in the U.S. for adults with early symptomatic Alzheimer’s disease.
Roast topics
Find topics
Find it!